35003
CVT-2738
Cayman Chemical
DESCRIPTION
An active metabolite of ranolazine; inhibits increases in T-wave height and the RR interval in a mouse model of isoprenaline-induced myocardial ischemia
DETAILS
- Inchi: InChI=1S/C14H21N3O/c1-11-4-3-5-12(2)14(11)16-13(18)10-17-8-6-15-7-9-17/h3-5,15H,6-10H2,1-2H3,(H,16,18)
- Purity: ≥98%
- Raptas: Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Receptor Pharmacology||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cardiovascular System|Cardiovascular Diseases|Myocardial Infarction||Research Area|Cardiovascular System|Heart|Arrhythmia||Research Area|Toxicology & Xenobiotic Metabolism|Cytochrome P450s||Research Area|Toxicology & Xenobiotic Metabolism|Drug Metabolites||Research Area|Toxicology & Xenobiotic Metabolism|Organ- & System-Specific Toxicity|Cardiovascular
- Smiles: O=C(CN1CCNCC1)NC2=C(C)C=CC=C2C
- Inchikey: NJKRFQIWDJSYOK-UHFFFAOYSA-N
- Cas Number: 5294-61-1
- Formulation: A solid
- Storage Temp: -20
- Shipping Temp: -20
- Formula Markup: C14H21N3O
- Formula Weight: 247.3
- Shelf Life Days: 1460